Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
